KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Tax Provisions (2021 - 2025)

Pacific Biosciences Of California has reported Tax Provisions over the past 4 years, most recently at $202000.0 for Q4 2025.

  • Quarterly results put Tax Provisions at $202000.0 for Q4 2025, down 36.08% from a year ago — trailing twelve months through Dec 2025 was $318000.0 (up 0.63% YoY), and the annual figure for FY2025 was $318000.0, up 0.63%.
  • Tax Provisions for Q4 2025 was $202000.0 at Pacific Biosciences Of California, down from $383000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for PACB hit a ceiling of $1.2 million in Q4 2021 and a floor of -$10.7 million in Q3 2023.
  • Median Tax Provisions over the past 4 years was $118500.0 (2025), compared with a mean of -$1.2 million.
  • Biggest five-year swings in Tax Provisions: surged 144.01% in 2024 and later tumbled 36.08% in 2025.
  • Pacific Biosciences Of California's Tax Provisions stood at $1.2 million in 2021, then tumbled by 161.11% to -$718000.0 in 2023, then surged by 144.01% to $316000.0 in 2024, then plummeted by 36.08% to $202000.0 in 2025.
  • The last three reported values for Tax Provisions were $202000.0 (Q4 2025), $383000.0 (Q3 2025), and $35000.0 (Q2 2025) per Business Quant data.